1 Background: In the United Kingdom pharmaceutical services can be delivered by both community 2 pharmacies (CPs) and dispensing doctor practices (DPs). Both must adhere to minimum standards 3 set out in NHS regulations however no common framework exists to guide quality improvement. 4
INTRODUCTION 25
In the UK, primary care pharmaceutical services can be provided by both community pharmacies 26 (CPs) and dispensing doctor practices (DPs). DPs are general medical practices that are able to 27 provide pharmaceutical services to patients who live in an area 'rural in character … more than one 28 mile (1.6km) from a pharmacy's premises' [1] . Both CPs and DPs have to meet minimum standards 29 of service provision set out in the National Health Services Pharmaceutical Services Regulations [2] . 30
However, separate reimbursement schemes and monitoring procedures exist for each provider. In 31
England, the NHS uses the Community Pharmacy Assurance Framework (CPAF) [3] to assess CPs' 32 compliance with the community pharmacy contractual framework. Most DPs opt to participate in 33 the separate Dispensary Services Quality Scheme (DSQS) [4] . 34
The CPAF and DSQS focus on ensuring CPs and DPs comply with a baseline level of quality. However, 35 the areas of service provision that focus on quality improvement (beyond a minimum baseline) are 36 not tightly regulated and are thus open to interpretation by individual providers. With the exception 37 of the focus group study of Halsall et al. [5] exploring quality in community pharmacy, there has 38 been very little work investigating ideal practice or the characteristics of good pharmaceutical 39 quality provision. This could both help guide service providers in striving to improve quality and be 40 used to inform a series of indicators suitable for judging the quality of pharmaceutical service 41 provision beyond a minimum baseline. In addition, a common set of characteristics for CPs and DPs 42 would help to ensure equity of service provision to patients, regardless of where they receive 43 pharmaceutical services. 44
The aim of this research was to develop a set of characteristics of good pharmaceutical services, 45 (focusing on service provision beyond the baseline level required by all providers), that could be 46 further refined into a quality improvement tool for use in both CPs and DPs. The research was 47 conducted in three phases, using a mixed-methods approach. The first two phases (surveys and case 48 studies of CPs and DPs) highlighted the overall similarity between CPs and DPs with regards to 49 pharmaceutical service provision [6], finding as much variation within groups (CP and DP) as 50 between. The first two phases led to the identification of a set of good service characteristics. The 51 third phase, reported here, involved a Delphi-type, two-round survey with key stakeholders, asking 52 them to confirm and rank the importance of these characteristics. 53
METHOD 54
Ethical approval for all three phases of the research was granted by the Southmead NHS Ethics 55 Committee on 31/08/11 (ref 11/SW/0203). Phase 1 used a postal questionnaire to CPs and DPs to 56 identify the services provided, areas of commonality and difference between CPs and DPs in service 57 provision and any monitoring systems in place to record services. These findings informed Phase 2 of 58 the research in which in-depth case studies of three CPs and four DPs took place. These were 59 thematically analysed [7] to investigate how the different procedures, systems and staff dynamics at 60 each site affected service provision over time. Through comparison and collation of data, the main 61 overall themes that related to quality of service provision were identified. These findings have been 62 published elsewhere [6] . 63 From these Phase 1 and 2 findings, the research team drew up an initial set of 22 characteristics of 64 good quality pharmaceutical service. The characteristics related to four broad categories: patient 65 safety and dispensing; patient-provider interaction; workplace culture; and public health. A two-66 round Delphi-type survey using the approach described by Hasson et al [8] was then conducted over 67 5 weeks in 2013, asking key stakeholders to confirm and rank the importance of the characteristics 68 identified. Participants for the Delphi-type survey were selected purposively to represent the views 69 of community pharmacists, dispensing GPs, dispensing staff at CPs and DPs, board members of CP 70 and DP professional organisations and lay persons. Invitations were also sent to relevant 71 professional organisations and two large, chain pharmacy companies. 72
Delphi participants could complete the surveys online or be posted paper copies. To protect 73 anonymity, participant group (pharmacist, GP, lay) was recorded but all other identifying 74 information was removed. In the first round of the survey, participants were presented with the 75 characteristics along with a brief description of what good engagement with each would look like in 76 practice ( Figure 1 ). Participants were asked to rate, on a scale of one to nine, the extent to which 77 they agreed each characteristic represented an important aspect of providing a good quality 78 pharmaceutical service (1 = completely disagree, 9 = completely agree). Participants were also 79 invited to comment on characteristics or suggest improvements. 80
In the second round, participants were provided with the median scores for each characteristic from 81 round one. They were asked to rate the extent to which they agreed each characteristic represented 82 an important aspect of good quality pharmaceutical service provision. Participants were asked to 83 rank the characteristics within each of the four main categories in order of importance. Finally, they 84 were asked to place those four categories in order of importance for pharmaceutical service quality. 85 Data were entered in PASW Statistics-18 software for analysis. Free text comments were subject to 86 content analysis: a list of categories derived from the data and research questions was drawn up and 87 data were systematically coded into these categories [9] . 88
RESULTS 89
Thirty-five people were directly contacted by the research team and invited to participate in the 90
Delphi. Several individuals also circulated the invitation within their organisations to colleagues, 91 making it impossible to calculate a response rate. Median ratings of the characteristics are given in Table 2 . In general the median ratings remained 98 the same across both rounds and all but one received a median rating of 7 or more. Several 99 characteristics received a wide range of ratings and the ranges did not decrease in round two, 100 indeed for some characteristics the diversity of ratings increased in the second round. However, 101 taking a definition of disagreement used in similar Delphi-type studies [10] of 30% or more of ratings 102 in both the 1-3 and 7-9 tertiles, there was not sufficient disagreement among participants for any of 103 the characteristics to be discounted. 104
Participants were asked to place the characteristics within each category in order of importance for 105 delivering pharmaceutical services. The mean rank assigned to each indicator was used to determine 106 the overall order of characteristics. The characteristics are displayed in Table 2 in Participants were not asked to rank all the characteristics across all groups (i.e. all 23 characteristics 115 in rank order) and so, for example, the top rated characteristic in the patient-provider interaction 116 category may not have been seen as less important than the bottom rated characteristic of the 117 patient safety and dispensing category. 118
Qualitative responses 119
Respondents were encouraged to offer comments on each of the characteristics. Although a diverse 120 range of opinions were expressed, there were no clear differences in the types of comments 121 expressed by the different respondent groups. That is, community pharmacists were not evidently 122 more favourable or negative towards particular characteristics than dispensing doctors or lay 123 respondents. 124
Patient Safety and Dispensing 125
All participants agreed that all staff members need to be involved in ensuring a culture of patient 126 safety and should be encouraged to reflect on the safety of current processes. However, there was 127 less agreement over the value of SOPs in helping to ensure safe practice, with some questioning 128 their usability: 129 "They are a good set of ideals … their shortfall is the detail. The volume and individual steps 130 are impossible to retain exactly and to practice exactly." (Community pharmacist 2) 131
There were also differences in opinions on how prescriptions should be checked, with some 132 participants viewing double checking (where a dispensed prescription is checked by two members of 133 staff) as the only correct way to practice and others feeling that, as long as systems are in place to 134 prevent errors (such as ensuring a gap is left between assembling and conducting the final check on 135 a prescription), single checking is acceptable. Although all participants agreed that interruptions 136 during dispensing heightened the risk of error, a few felt that the suggestion to keep interruptions to 137 a minimum could be misinterpreted or would be unfeasible: 138 All participants agreed that recording and reflecting on errors and near misses is important; 142 unfortunately some of the participants working in CPs and DPs reported that there was a tendency 143 to blame individuals, which prevented reporting and learning from errors. 144
Patient-provider interaction 145
Most participants strongly agreed with the importance of demonstrating a patient-centred ethos. 146
Only one participant disagreed, feeling that patients needed to take more responsibility for their 147 health. One participant disagreed with the importance of staff ensuring patients understand why 148 and how to take their medications, believing this to be the prescriber's role. 149
Although a few participants felt that staff training on communication would not be feasible in 150 smaller practices, several highlighted the importance of good staff-patient communication, not only 151 for business purposes but also for ensuring treatment adherence and picking up on potential 152 problems: 153 "It is an important role that can influence patient's compliance and identify possible 154 problems. I'm not sure this is given a high enough priority in dispensaries but it will become 155 more essential as the population ages." (Lay member 1) 156
Engaging with patients to ensure good customer service was agreed to be important by all but 157 several people disagreed with the need for a SOP on handling times when staff are unable to 158 immediately deal with a patient: The service characteristic concerning medicines use reviews (MURs) and dispensing reviews of use of 165 medicines (DRUMs) was divisive: several participants agreed that these checks should only be 166 carried out with patients whom staff believe would benefit from a review. However, some 167 participants pointed out that it is hard to tell the potential value of a review beforehand: 168 "You often don't know the full benefit till you start the consultation with the patient and 169 appreciate their unspoken needs." (Community pharmacist 3) 170
However, if staff have the freedom to decide when to conduct an MUR, the fear was that they might 171 not conduct any. 172
A member of staff who is pressed for time may decide that there is nothing to be gained by 173 conducting a MUR / DRUM, whereas the patient might clearly benefit from one. (Lay 174 member 2) 175
Workplace culture 176
All participants agreed that having established methods of communication among staff is important 177 for providing good quality service. Promoting an ethos where staff feel able to make suggestions for 178 improvements and to learn about other providers' systems was generally deemed important. 179
Training and CPD were mostly acknowledged as important for providing "better qualified staff, more 180 self-confidence and job satisfaction, and better patient care" (Community pharmacist 4). However, 181 several of the participants reported that some mandatory courses had been irrelevant and they 182 could not see how study time could be integrated into an already busy schedule. 183
Linking up with other providers to share knowledge and experience was seen as something to aim 184 for, but unlikely to happen due to time pressures, confidentiality regulations and, possibly, 185 competition for business hindering attempts to work together: 186 "Good idea.... But for a busy GP practice with several different pharmacies surrounding it..... 187
[I] question the practicality" (Community Pharmacy Executive 2) 188

Public health 189
While the majority of participants felt that it was important for all staff in a CP or DP dispensary to 190 be able to provide up-to-date public health information, two participants felt that this was the role 191 only of the pharmacist, practice nurse or GP. Overall, the public health characteristics were seen as 192 less important than those in the other categories, with several participants viewing public health as 193 'secondary' or 'peripheral' to pharmaceutical services. So, although having well-presented 194 information of available services was seen as ideal and "a good place to give health advice" 195 (Dispensing GP 2), this should not be "at the expense of (for example) a well-stocked pharmacy" (Lay 196 member 2). On the other hand, there were also several comments highlighting that health 197 promotion is an "increasingly important role" (Community pharmacist 5) for all staff in primary care. 198 A lack of space was reported as a common barrier to providing better health promotion and public 199 health services. 200
DISCUSSION 201
The study addressed areas of service provision that focus on quality improvement beyond a 202 minimum baseline that are not tightly regulated and therefore are open to interpretation by 203 individual providers. Of the 23 characteristics investigated, all were rated as being important aspects 204 of pharmaceutical service provision, with characteristics relating to patient safety perceived to be 205 the most important. This study is the first to characterise the quality of pharmaceutical service 206 provision across both CPs and DPs. 207
All the characteristics identified were retained as being important throughout the Delphi, and it may 208 be that it was not possible for respondents to make distinctions between the different 209 characteristics in terms of assessing importance. This was a relatively small study and, despite 210 The ambivalence towards public health practices revealed in participants' comments seems 223 particularly noteworthy given the United Kingdom Department of Health's current emphasis on 224 health promotion and shift towards preventive care [12] . There seemed to be a belief among some 225 participants that, although public health and health promotion campaigns were important, they 226 were not within the remit of primary care. The need for better acknowledgement by primary care 227 practitioners of their role in public health has been reported previously [13] . While primary care 228 professional bodies have produced resources to help practices increase their involvement in public 229 health [14, 15] , more action needs to be taken if the Department of Health's aims are to be met. 230
In addition to investigating the applicability of these characteristics in a wider population of CPs and 231
DPs, further work is needed to develop and test a tool, based on the characteristics, that helps staff 232 at CPs and DPs to identify areas where quality could be improved and then to make changes to 233 practice. It is important to bear in mind, however, that assessing performance can lead to 234 dysfunctional consequences [16] called 'measurement fixation': where staff focus solely on meeting 235 specific targets rather than understanding the 'spirit' of the characteristic. While some of the 236 characteristics might be easily assessed using traditional measures (such as number of dispensing 237 errors), it has been the aim of the research team, in agreement with recommendations by the King's 238
Fund [17] , not to ignore those aspects of quality that are less easily quantifiable, such as culture, 239 ethos and morale. Therefore innovative qualitative methods are also called for. Examples suggested 240 include "mystery shopper"-style visits to assess specific aspects of patient-provider interaction and 241 health promotion, random spot checks to assess staff understanding of SOPs, auditing the reasons 242 behind un-filled prescriptions, and keeping minutes of staff meetings to review errors. It will be 243 important to ascertain what form of quality improvement resource service providers would find 244 most useful. For example, a reflective framework, similar to the Manchester Patient Safety 245
Framework [18], could provide users with descriptions of what increasing quality looks like on each 246
of the characteristics found in the present study. 247
CONCLUSION 248
A set of 23 characteristics defining good quality pharmaceutical service provision in DPs and CPs has 249 been developed, covering patient safety and dispensing, patient-provider interaction, workplace 250 culture, and public health. These findings suggest that the characteristics, devised from two earlier 251 phases of the research, were agreed by our participants to represent important aspects of providing 252 good quality pharmaceutical services. Given the recent policy emphasis on patient safety, it is 253 unsurprising that patient safety was perceived to be the most important aspect of good quality 254 pharmaceutical service provision. However, it is interesting to note that some respondents were 255 ambivalent about the importance of public health, a view at odds with current health policy 256 initiatives and the increasing role of the pharmacist. Further work is needed to develop a tool to 257 guide quality improvement. This could take the form of a reflective resource for service providers 258 that will help them identify areas where quality could be improved and ultimately help them make 259 changes to their practice that promotes quality. 260 Description: There are agreed methods for communicating different types of messages (e.g. new protocols will be listed on a noticeboard for all staff to sign when they have read them; issues that cannot be resolved that day concerning a particular prescription are to be noted in the diary for next staff etc.). These methods are documented in a standard operating procedure (SOP) and, if appropriate, the SOP is also displayed as a poster in the dispensary for the benefit of locum/new staff. Regular practice review meetings should be held with all staff present or receiving minutes. Staff feel that they are listened to by their colleagues. Staff are required to reflect on how effective the communication systems are within the team at least annually. Sites link up to run DP and CP staff discussion groups on relevant issues. 6.5 1-9 6.0 1-9 6.27
Public health 1 Practice / Pharmacy staff are well equipped to provide essential public health advice.
8.0 1-9 8.0 3-9 2.18 2 There is good use of patient waiting areas for health promotion and advice. ** MURs = medicines use reviews, DRUMs = dispensing reviews of use of medicines; these are patient 336 consultations, conducted at CPs and DPs respectively, aiming assess how a patient is taking their medication 337 and if they are experiencing any problems. 338 ***This characteristic relates to CPs only.
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